Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Phys Rev Lett ; 103(12): 122501, 2009 Sep 18.
Article in English | MEDLINE | ID: mdl-19792426

ABSTRACT

The ground-state-to-ground-state Q_{beta;{-}} value of ;{115}In was determined to 497.68(17) keV using a high-precision Penning trap facility at the University of Jyväskylä, Finland. From this, a Q_{beta;{-}} value of 0.35(17) keV was obtained for the rare beta;{-} decay to the first excited state of ;{115}Sn at 497.334(22) keV. The partial half-life was determined to 4.1(6) x 10;{20} yr using ultra low-background gamma-ray spectrometry in an underground laboratory. Theoretical modeling of this 2nd-forbidden unique beta;{-} transition was also undertaken and resulted in Q_{beta;{-}} = 57_{-12};{+19} eV using the measured half-life. The discrepancy between theory and experiment could be attributed to atomic effects enhanced by the low Q value. The present study implies that this transition has the lowest Q value of any known nuclear beta decay.

2.
J Antimicrob Chemother ; 31 Suppl E: 177-83, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8396091

ABSTRACT

One hundred and twenty male patients with signs and symptoms compatible with non-gonococcal urethritis were enrolled in a prospective-randomized study to compare the efficacy and safety of a single oral-dose of 1 g azithromycin and a seven-day course of 100 mg doxycycline twice-daily. Clinical examination and culture samples for Chlamydia trachomatis were performed before and approximately 8, 15 and 35 days after starting treatment. Both treatment groups were comprised of 30 chlamydia-positive patients evaluable for efficacy. The eradication rate of C. trachomatis in baseline-positive patients at the first follow-up visit in the azithromycin group was 96% with one persistent case, and 100% in the doxycycline group. After about two weeks, there were two re-occurrences in the azithromycin group, resulting in a cumulative eradication rate of 90% with three culture-positive cases. The corresponding figure in the doxycycline group was still 100%, but there were leucocytes present in the urethral smear of two patients who later proved to be true culture-positive re-occurrences. After about five weeks, there was an additional re-occurrence in the azithromycin group leading to a cumulative eradication rate of 87%, while two re-occurrences in the doxycycline group gave a cumulative eradication rate of 93%. There was no statistically significant difference in efficacy between the single-dose azithromycin and seven-day course of doxycycline in the treatment of patients with chlamydial urethritis.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Chlamydia Infections/drug therapy , Chlamydia trachomatis , Doxycycline/therapeutic use , Erythromycin/analogs & derivatives , Neisseria gonorrhoeae , Neisseriaceae Infections , Ureaplasma Infections/drug therapy , Ureaplasma urealyticum , Urethritis/drug therapy , Administration, Oral , Adolescent , Adult , Azithromycin , Doxycycline/adverse effects , Drug Administration Schedule , Erythromycin/adverse effects , Erythromycin/therapeutic use , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Urethritis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...